Webinar-Preparing for Phase 1: Strategies for Success in Advancing your Drug to First-in-Human Trials
Summary: Companies can encounter a number of pitfalls on the path to moving a drug from preclinical to clinical trials. Understanding these hurdles—and properly preparing for them—can prevent a drug development program from stalling or worse, stopping altogether.
Biopharma companies encounter a wide range of challenges as their molecules move towards first-in-human trials, including bioavailability issues, shortfalls in supplies of active pharmaceutical ingredients and misunderstandings during the IND process that prevent phase 1 trials from moving forward.
During this webinar, biopharma R&D professionals will review strategies for moving successfully and efficiently from preclinical studies to first-in-human trials. They will call upon their own experiences to provide advice that will help others in the industry navigate this crucial transition.